Trading Ideas

Zoom is more popular than ever, but it’s also been criticized for poor security and privacy. Here’s how to still use it and stay safe. …read more […]

According to a report by the Financial Times, Gilead Science Inc’s experimental antiviral drug Remdesiver, which was being used to treat coronavirus, failed to improve the health of patients. Yahoo Finance’s Anjalee Khemlani joins The Final Round panel to break down the latest news about the coronavirus. …read more […]

(Bloomberg) — Gilead Sciences Inc. analysts offered a broad range of views on the inadvertently leaked abstract that indicated the company’s remdesivir failed to provide a benefit in a placebo-controlled trial in Chinese patients with severe Covid-19.Skeptical analysts included Baird’s Brian Skorney, who said the negative results “should be very sobering” given the lack of an improvement and argued that the result is “pretty close to a worst case scenario.” Others on Wall Street argued that investors should hold off on jumping to conclusions.“The bottom line is that stating the trial flopped appears overly aggressive and premature, particularly in light …read more […]

How far are we from a viable COVID-19 treatment? Worldwide, over 178,000 people have died so far, with confirmed cases numbering more than 2,500,000. More than 150 drugs are being researched as possible treatments, by companies big and small.Pluristem Therapeutics (PSTI) falls squarely into the latter category. The micro-cap pharma company has been grabbing some attention with its potential COVID-19 treatment.Following a virtual fireside chat with Pluristem’s President and CEO Yaky Yanay, H.C. Wainwright’s Swayampakula Ramakanth noted, “In our view, with the ongoing pandemic affecting nearly every country and stressing healthcare systems around the world, there is an urgent need …read more […]

The coronavirus pandemic showed signs of waning on Thursday, but its economic impact was as destructive as ever. …read more […]

Yahoo Finance’s Anjalee Khemlani joins Seana Smith to break down the latest development in Gilead’s coronavirus treatment. …read more […]

The US economy is facing the worst contraction in modern history – and a “confidence shock” will slow down its recovery, says one economist. …read more […]

Many of the $1,200 stimulus checks have yet to arrive and some are already pushing for more – perhaps much more – in the coming months. …read more […]

Neptune Wellness Solutions Inc.’s shares (NEPT) popped more than 30% on Thursday following plans to boost its weekly production of hand sanitizer to over 1 million units to meet strong demand fueled by the coronavirus outbreak.Neptune, a Canadian-based producer of health products, announced that its subsidiary Biodroga, has accelerated the production of hand sanitizers ahead of time in response to a supply shortage and strong demand from North American retail and government customers as the COVID-19 pandemic continues to take its toll.The company plans to begin shipping the hand sanitizer next week, including fulfilling a purchase order from a large …read more […]

(Bloomberg) — How can traders in the equity market be so sanguine when economic tumult on the order of a depression is blaring all around them? Possibly because they expected even worse.That’s one takeaway from data compiled by Charles Schwab Corp. on the brokerage’s most active clients, which shows almost 60% were bracing for volatility to rise in the second quarter. Dread is a natural emotion when things are falling apart, but that’s an awfully pessimistic take considering the first three months of the year saw equity turbulence surpass levels seen in the 2008 financial crisis.“Nobody knows what to expect …read more […]

In a note on Thursday, MUFG Chief Financial Economist Chris Rupkey warned that the 26 million unemployment claims filed in the U.S. amid the coronavirus pandemic could have dire implications for the future of the U.S. economy. Rupkey joins Yahoo Finance’s Zack Guzman to break it down. …read more […]

The market is a leading indicator that reflects the knowledge of millions of investors.
And right now, as Alexander Green explains, it’s telling investors that things are looking up.

We’ve seen some dramatic market action over the last two months.
A nearly 11-year bull market turned into a bear market in less than four weeks, the fastest on record.
From its high on February 19, the S&P 500 fell more than 35% to its March 23 low.
It then bounced more than 25% off the bottom over the next three weeks.
Since then we’ve had up days and down days, but the market has mostly held …read more […]

Strategists weigh in on how much economic gloom the stock market has priced into up to now. …read more […]

…read more […]

President Trump says he disagrees with Georgia Governor Brian Kemp’s decision to reopen non-essential businesses during the coronavirus pandemic. Yahoo Finance’s Rick Newman shares the details. …read more […]